Bortezomib/Cyclophosphamide/Dexamethasone/Rituximab Regimen

Preferred Label : Bortezomib/Cyclophosphamide/Dexamethasone/Rituximab Regimen;

NCIt synonyms : Bortezomib/Cyclophosphamide/Dexamethasone/Rituximab; Bortezomib-Cyclophosphamide-Dexamethasone-Rituximab; Velcade/Cytoxan/Decadron/Rituxan; Bortezomib/Cyclophosphamide/Dexamethasone Plus Rituximab; Bortezomib-DRC Regimen; B-DRC; B-DRC Regimen;

NCIt definition : A regimen consisting of bortezomib, cyclophosphamide, dexamethasone, and rituximab that may be used in the treatment of Waldenstrom macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL).;

Détails

Origin ID

C213255;

chemotherapy_regimen_has_component
- Bortezomib [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Dexamethasone [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients